Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T17:33:22.553Z.
Calculation as of: 2026-10-06T17:33:22.553Z.
Quote observation: 2026-10-06T17:30:09.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 0fde8dae4c5ae63ee7b35c7e6e46bba2fdf5d6d5db310b32cf0eb41a7e17e840
EARNINGS YIELD
N/A
Obsidian Therapeutics Inc.
Market Cap
$14.14M
Earnings Yield
N/A
| NAME | MARKET CAP | EARNINGS YIELD |
|---|---|---|
| Obsidian Therapeutics Inc. (OBX) | $14.14M | N/A |
| Pulsenmore Ltd. Ordinary Shares (PLSM)vs › | $14.11M | N/A |
| Sintx Technologies, Inc. (SINT)vs › | $13.66M | N/A |
| Vyome Holdings, Inc. (HIND)vs › | $13.62M | N/A |
| Citius Pharmaceuticals, Inc. (CTXR)vs › | $13.55M | N/A |
| Optimi Health Corp. (OPTH)vs › | $13.36M | N/A |
| IN8bio, Inc. (INAB)vs › | $13.35M | N/A |
| Pasithea Therapeutics Corp. (KTTA)vs › | $14.87M | N/A |
| Passage Bio, Inc. (PASG)vs › | $12.88M | N/A |
| Cellectar Biosciences, Inc. (CLRB)vs › | $12.62M | N/A |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
